Key facts
- This page summarizes Kevin Kometer's Form 4 filing for CME GROUP INC. (CME).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2022, 15:00.
Kevin Kometer - 10 Feb 2022 Form 4 Insider Report for CME GROUP INC. (CME)
- Reporting relationship
- Sr MD Chief Information Office
- Issuer ticker
- CME
- Reported as of
- 10 Feb 2022
- Net transaction value
- -$3,294,504
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2022, 15:00:38 UTC
- Prior SEC filing
- 17 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- By: Margaret Austin Wright For: Kevin Kometer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Kometer filed Form 4 for CME GROUP INC. (CME) on 14 Feb 2022.
Change
- Previous filing in this sequence was filed on 17 Sep 2021.
- Current net transaction value: -$3,294,504.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CME
transaction
Common Stock Class A
Sale
- Transaction value
- $525,185
- Shares
- -2,143
- Change %
- -2.8%
- Price
- $245.07
- Shares after
- 74,564
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
CME
transaction
Common Stock Class A
Sale
- Transaction value
- $1,235,669
- Shares
- -5,057
- Change %
- -6.8%
- Price
- $244.35
- Shares after
- 69,507
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
CME
transaction
Common Stock Class A
Sale
- Transaction value
- $1,533,649
- Shares
- -6,300
- Change %
- -9.1%
- Price
- $243.44
- Shares after
- 63,207
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On February 10, 2022, Mr. Kometer sold an aggregate of 2,143 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $244.87 to $245.30. The Company maintains a record of the transaction and copies will be provided upon request.
Footnote F2
On February 10, 2022, Mr. Kometer sold an aggregate of 5,057 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $243.85 to $244.805. The Company maintains a record of the transaction and copies will be provided upon request.
Footnote F3
On February 10, 2022, Mr. Kometer sold an aggregate of 6,300 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $242.84 to $243.84. The Company maintains a record of the transaction and copies will be provided upon request.